What does biotechnology — operating income mean?

The profit or loss generated by the segment's core business operations before interest and taxes.

How do you interpret biotechnology — operating income?

An increase indicates improved operational efficiency or higher margins, while a decrease suggests rising costs or declining segment performance.

How does biotechnology — operating income compare across companies?

Operating margins in life science segments are typically benchmarked against industry peers to assess competitive cost structures.

Bio-Techne TECH Biotechnology — Operating Income

Discontinued — last reported Q4 '18

Similar metrics at other companies

GTLSBiomedical — Operating Income

$11.11M+186%

HSICTechnology — Operating Income

$36.25M—

ALife Sciences and Applied Markets — Operating Income (Loss)

$233M-2.9%

STELife Science Member — Operating Income (Loss), Before Adjustments

$58.7M+11.6%

BIO.BOperating Segments — Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments

——

BIO.BLife Science — Income from operations

——

Other financials

Income statement

See full

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

See full

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

See full

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

See full

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

See full

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Bio-Techne’s 10-K, filed August 27, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does biotechnology — operating income mean?: The profit or loss generated by the segment's core business operations before interest and taxes.
How do you interpret biotechnology — operating income?: An increase indicates improved operational efficiency or higher margins, while a decrease suggests rising costs or declining segment performance.
How does biotechnology — operating income compare across companies?: Operating margins in life science segments are typically benchmarked against industry peers to assess competitive cost structures.